Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)) MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))
Unique ID
C032690
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C032690
Entry Term(s)
17 beta-hydroxysteroid-NAD+ 17-oxidoreductase
17-beta-HSD
17-ketoreductase
3 alpha(17 beta)-hydroxysteroid dehydrogenase (NAD+)
3,17-HS dehydrogenase
testosterone 17 beta-dehydrogenase
Registry Numbers
EC 1.1.1.239
EC 1.1.1.64
Related Numbers
EC 1.1.1.239
EC 1.1.1.64
Heading Mapped to
*17-Hydroxysteroid Dehydrogenases
Frequency
119
Note
catalyzes reversibly the oxidation of testosterone to 4-androstene-3,17-dione in the presence of NAD
Source
Arch Biochem Biophys 1981;212(1):63
Date of Entry
1981/12/30
Revision Date
2018/09/24
3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)) Preferred
testosterone 17 beta-dehydrogenase Narrower
page delivered in 0.004s